In a patient with septic shock requiring initiation of norepinephrine, should the target mean arterial pressure be limited to 65 mm Hg or increased to a more normal range such as 90 mm Hg?

Target MAP of 65-70 mmHg in Septic Shock

For most patients with septic shock requiring norepinephrine, you should target an initial MAP of 65-70 mmHg rather than 90 mmHg. The most recent 2025 ESICM guidelines and 2016 Surviving Sepsis Campaign both strongly recommend this lower target as the standard approach 1222222.

The Evidence Base

The landmark SEPSISPAM trial 3 directly compared high MAP targets (80-85 mmHg) versus low targets (65-70 mmHg) in 776 patients with septic shock. At both 28 days and 90 days, there was no mortality difference between groups (36.6% vs 34.0% at 28 days; 43.8% vs 42.3% at 90 days). This is the highest quality evidence addressing your exact question, and it definitively shows that pushing MAP to 80-85 mmHg (closer to your proposed 90 mmHg) does not improve survival.

Critical Exception: Chronic Hypertension

The one important exception is patients with chronic arterial hypertension. In the SEPSISPAM trial, chronically hypertensive patients in the high MAP target group required significantly less renal replacement therapy 3. The 2025 ESICM guidelines explicitly state that "a higher MAP target may be considered in patients with septic shock and a history of chronic arterial hypertension who show clinical improvement with higher blood pressure" 1.

Practical Algorithm:

For patients WITHOUT chronic hypertension:

• Target MAP 65-70 mmHg
• No benefit from higher targets
• Lower risk of atrial fibrillation (which was more common with higher MAP targets 3)

For patients WITH chronic hypertension:

• Start with MAP 65-70 mmHg
• If signs of inadequate perfusion persist (oliguria, altered mentation, elevated lactate) despite adequate fluid resuscitation
• Consider increasing MAP target to 75-85 mmHg
• Monitor for clinical improvement in organ perfusion
• The 2025 guidelines also suggest higher targets may benefit patients with high CVP values who show clinical improvement 1

Why Not Target 90 mmHg?

Targeting MAP of 90 mmHg would require excessive norepinephrine doses, which carry significant risks 4:

• Cardiac complications: Increased risk of atrial fibrillation, arrhythmias, and stress cardiomyopathy
• Excessive vasoconstriction: Can paradoxically worsen tissue perfusion despite higher MAP, leading to ischemic injury and potential gangrene of extremities
• Microcirculatory dysfunction: Higher MAP achieved through vasoconstrictors doesn't guarantee improved microcirculatory flow 5

The FDA label for norepinephrine specifically warns that "prolonged administration of any potent vasopressor may result in...severe peripheral and visceral vasoconstriction with diminution in blood flow and tissue perfusion" 4.

Individualization Based on Perfusion, Not Arbitrary Targets

Recent evidence increasingly emphasizes that MAP is a means to an end (organ perfusion), not the end itself 67. The 2025 ESICM guidelines state that "the target blood pressure should be individualized during resuscitation" 1, but this means adjusting based on perfusion markers, not arbitrarily choosing higher numbers.

Monitor these perfusion endpoints:

• Lactate clearance
• Urine output (≥0.5 mL/kg/hr)
• Mental status
• Capillary refill time
• Skin mottling

If these markers improve at MAP 65-70 mmHg, there is no justification for escalating to 90 mmHg. Conversely, if perfusion remains inadequate despite MAP 65-70 mmHg and adequate fluid resuscitation, consider modest increases (to 75-85 mmHg range), particularly in chronically hypertensive patients.

Common Pitfalls to Avoid

1. Don't chase an arbitrary high MAP number - The SEPSISPAM trial showed no mortality benefit 3
2. Don't assume higher MAP equals better perfusion - Excessive vasoconstriction can worsen microcirculatory flow 5
3. Don't ignore chronic hypertension history - This is the one subgroup that may benefit from higher targets 38
4. Don't forget fluid resuscitation first - Vasopressors should not substitute for adequate volume resuscitation 24

The evidence strongly supports starting with MAP 65-70 mmHg for the vast majority of septic shock patients, with selective escalation to 75-85 mmHg (not 90 mmHg) only in chronically hypertensive patients showing inadequate perfusion at lower targets.